Cellcure Cancer Centre Private Limited

Cellcure Cancer Centre Private Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U74999MH2017PTC301138 Incorporated 25 October 2017 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company healthcare MSME
Data last updated
Revenue · FY 2026
₹445.56 Cr
▲ 33% YoY
Net profit · FY 2026
₹15.57 Cr
Net margin 3.5%
EBITDA · FY 2026
₹31.35 Cr
EBITDA margin 7%
Authorised capital
₹3.57 Cr
Registered with MCA
Paid-up capital
₹1.58 Cr
Issued & subscribed
Satisfied charges
₹2.3 Cr
No open charges
Company age
9 yrs
Est. 2017
Employees · EPFO
354
Provident fund records

About Cellcure Cancer Centre Private Limited

Data last updated:

Cellcure Cancer Centre Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the hospital and clinical services segment of the healthcare sector. It was incorporated on 25 October 2017 and has been in existence for over 9 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2017PTC301138. Its GSTIN is 27AAHCC2532P2ZC (Maharashtra). The company holds 4 GST registrations, of which 3 are active.

The company has an authorised share capital of ₹3.57 Cr and a paid-up capital of ₹1.58 Cr. It is led by directors including Mayank Khanduja and Vashista Pankaj Maniar.

Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2026, the company reported a revenue of ₹445.56 Cr, a growth of 33% compared to the previous year. For the same year it recorded a net profit of ₹15.57 Cr (net margin 3.5%) and EBITDA of ₹31.35 Cr (EBITDA margin 7%). Revenue has grown at a compounded annual rate (CAGR) of 61% over three years and 57% over five years.

The company has about 354 employees on its provident fund (EPFO) records.

The company is associated with 2 brands: MOC Cancer Care Foundation and MOC India. As per MCA filings, the company has satisfied charges of ₹2.3 Cr on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending. The company has 8 deals on record (4 funding rounds, 4 secondary share transfers), with disclosed funding of ₹201.45 Cr; the latest was in March 2025. The company has 17 MSME Form 1 returns on record between 2019 and 2024, listing 302 overdue payments to 32 micro and small suppliers.

Cellcure Cancer Centre Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-19-0033135). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mocindia.co.in.

Company details

CIN U74999MH2017PTC301138
Registration Number 301138
Incorporation Date 25 October 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-19-0033135
Key People
Mayank Khanduja Director Vashista Pankaj Maniar Director Bhavin Ashokbhai Shah Director

Recognitions & Rankings of Cellcure Cancer Centre

MSME (Udyam registered) Ministry of MSME
Udyam number
UDYAM-MH-19-0033135

Contact details

Cellcure Cancer Centre Private Limited's registered office is in Mumbai, Maharashtra. Its website is mocindia.co.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    mocindia.co.in
  • Social Media
  • Registered Address
    1st & 2nd Floor Shree Saraswati Apartments, Chsl Opposite Bhagwati Hospital S.V. Road, Mumbai, Maharashtra, India – 400092
  • Industry
    Healthcare, Hospitals

To see the full contact details of Cellcure Cancer Centre Private Limited, buy the company report.

Comprehensive company report
Cellcure Cancer Centre Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Cellcure Cancer Centre operates two associated brands: MOC Cancer Care Foundation and MOC India. Each brand links to its own profile.

BrandDescriptionWebsite
MOC India
Oncology and hematology services are delivered via clinic chains.mocindia.co.in
MOC Cancer Care Foundation
Cancer care foundation offering patient support and research funding in India.mocfoundation.com

Business activity

The main business activity of Cellcure Cancer Centre is human health and social work activities. In detail, this covers human health activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHuman health and social work activities86Human health activities

To see the full business activity and turnover split of Cellcure Cancer Centre Private Limited, buy the company report.

Financials of Cellcure Cancer Centre Private Limited

FY 2026 filings available

Cellcure Cancer Centre Private Limited reported revenue of ₹445.56 Cr (up 33% YoY) for FY 2026.

Revenue · FY 2026
₹445.56 Cr ▲ 33%
Net profit · FY 2026
₹15.57 Cr margin 3.5%
EBITDA · FY 2026
₹31.35 Cr margin 7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 33%
3 years · compounded
▲ 61%
5 years · compounded
▲ 57%
EBITDA CAGR growth
1 year
▲ 211%
3 years · compounded
▲ 128%
5 years · compounded
▲ 24%

Revenue has grown at a compounded annual rate (CAGR) of 57% over five years, including 33% growth in the latest year. EBITDA rose 211% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹445.56 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹31.35 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹15.57 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin7%
Net Profit Margin3.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Cellcure Cancer Centre Private Limited, buy the company report.

Board of directors of Cellcure Cancer Centre Private Limited

Cellcure Cancer Centre has 7 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Mayank Khanduja
Also directs: Light Ray Advisors LLP, Firstprinciple Appsforbharat Private Limited, Nobroker Technologies Solutions Private Limited and 2 more
Director13 Mar 20251 Years 7 MonthsCurrent
Vashista Pankaj Maniar
Also directs: Moc Cancer Care Foundation
Director25 Oct 20179 Years 0 MonthsCurrent
Bhavin Ashokbhai ShahDirector24 May 20242 Years 5 MonthsCurrent
Ashish Anand Joshi
Also directs: Moc Cancer Care Foundation
Director25 Oct 20179 Years 0 MonthsCurrent
Kshitij Chandrakant Joshi
Also directs: Moc Cancer Care Foundation, Sameforever Private Limited, Sameforever Private Limited
Director25 Oct 20179 Years 0 MonthsCurrent
Preetam Baban Kalaskar
Also directs: Moc Cancer Care Foundation, Sameforever Private Limited, Sameforever Private Limited
Director25 Oct 20179 Years 0 MonthsCurrent
Showing 6 of 7 current directors. View all directors

Auditor

Cellcure Cancer Centre Private Limited is audited by KKC & Associates LLP for the financial year 2026.

Auditor firmFinancial yearFirm registration number
KKC & Associates LLPFY 2026105146W/W100621

Shareholding

The shareholding of Cellcure Cancer Centre Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2025FY 2024FY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Cellcure Cancer Centre Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹2.3 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹2.30 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
15 Nov 2022100651004Hdfc Bank Limited₹2.3 CrSatisfied

To see the full charge records of Cellcure Cancer Centre Private Limited, buy the company report.

Total charge records: 1 View all charges

Deals & funding

Cellcure Cancer Centre Private Limited has 8 deals on record (4 funding rounds, 4 secondary share transfers), with disclosed funding of ₹201.45 Cr; the latest was in March 2025.

Total deals
8
Funding rounds
4
Secondary share transfers
4
Disclosed funding
₹201.45 Cr

Deals on record (5 of 8)

WhenDealAmountParties
Mar 2025Funding round · Series B₹125 CrInvestors: Elevation Capital (SAIF Partners)
Jun 2023Secondary share transferUndisclosedBuyer: 2 individuals
Seller: an individual
Apr 2023Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Feb 2023Funding round · Series A₹75 CrInvestors: Tata Capital Healthcare Fund
Apr 2021Secondary share transferUndisclosedSeller: 4 individuals

To see the full deal history of Cellcure Cancer Centre Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Cellcure Cancer Centre Private Limited has 17 MSME Form 1 returns on record between 2019 and 2024, listing 302 overdue payments to 32 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 32)

SupplierAmount dueDue sinceReported on
Novacare Healthcare Solutions Private Limited
Impact Design Cell
an individual supplier
P.B.P Enterprises Private Limited
Certaincure Pharma Private Limited

To see the full MSME payment records of Cellcure Cancer Centre Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Cellcure Cancer Centre Private Limited has a workforce of 354 employees on its EPFO records as of Mar 31, 2024, across 1 active EPFO establishment.

Employee count
354
Active EPFO establishments
1
Employee growth
33.58%

GST

Cellcure Cancer Centre has 4 GST registrations: 3 active and 1 cancelled or inactive.

Total GSTINs
4
Active
3
Cancelled / inactive
1
GSTINStateStatusRegistered on
27AAHCC2532P2ZCMaharashtraActive14 Jun 2022
24AAHCC2532P1ZJGujaratActive28 Apr 2025
07AAHCC2532P1ZFDelhiActive30 May 2025

To see the full GST registrations and return filing status of Cellcure Cancer Centre Private Limited, buy the company report.

Recent activity

Cellcure Cancer Centre Private Limited has 15 board changes on record since 2017: 8 appointments and 7 cessations. The latest: Visalakshi Chandramouli was appointed as Additional Director on 29 Nov 2025.

Filing
Cellcure Cancer Centre Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai.
Appointed
Visalakshi Chandramouli was appointed as Additional Director.
AGM
Cellcure Cancer Centre Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Appointed
Mayank Khanduja was appointed as Director.
Ceased
Mayank Khanduja ceased to be Additional Director.
Charges
A charge registered on 15 Nov 2022 via Charge ID 100651004 with Hdfc Bank Limited was fully satisfied on 31 Jul 2024.
Appointed
Bhavin Ashokbhai Shah was appointed as Director.
Ceased
Bhavin Ashokbhai Shah ceased to be Additional Director.
Ceased
Vamesh Bhupendra Chovatia ceased to be Additional Director.
Appointed
Vamesh Bhupendra Chovatia was appointed as Director.
Charges
A charge with Hdfc Bank Limited of Rs. 2.30 Cr registered on 15 Nov 2022 with Charge ID 100651004 was modified on 31 Jan 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2.30 Cr with Charge ID 100651004 was registered on 15 Nov 2022.

9 earlier events are in the company report.

News

Frequently asked questions

Cellcure Cancer Centre is an active private limited company based in Mumbai, Maharashtra, India. The company works in hospitals, within the healthcare industry. It was incorporated on 25 October 2017 (9+ years old) and is registered under CIN U74999MH2017PTC301138.

Cellcure Cancer Centre has 7 current directors:

The latest financial statements of Cellcure Cancer Centre on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 26 September 2025. Year-wise statements from FY 2018 are in the company report.

The GSTIN of Cellcure Cancer Centre is 27AAHCC2532P2ZC, registered in Maharashtra. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 24AAHCC2532P1ZJ (Gujarat), 07AAHCC2532P1ZF (Delhi).

The CIN (Corporate Identification Number) of Cellcure Cancer Centre is U74999MH2017PTC301138. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Cellcure Cancer Centre has 1 court case on record: 1 filed by the company. 1 is pending.

Cellcure Cancer Centre was incorporated on 25 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.

Cellcure Cancer Centre has 8 deals on record (4 funding rounds, 4 secondary share transfers), with disclosed funding of ₹201.45 Cr; the latest was in March 2025.

Visalakshi Chandramouli was appointed as Additional Director on 29 Nov 2025. Mayank Khanduja was appointed as Director on 13 Mar 2025. Mayank Khanduja ceased to be Additional Director on 13 Mar 2025. Cellcure Cancer Centre has 15 board changes on record in total.

Yes, Cellcure Cancer Centre is registered as an MSME under Udyam registration (number: UDYAM-MH-19-0033135).

Cellcure Cancer Centre has 17 MSME Form 1 returns on record between 2019 and 2024, listing 302 overdue payments to 32 micro and small suppliers. The latest return was filed on 23 Apr 2024.